January 21 2024 - FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment

January 21 2024 - FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment

FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
Boston Scientific sees success in PFA device trial
Sionna, Odyssey join queue of biotechs testing investors’ IPO interest
Trump signs executive order to leave World Health Organization
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*
image: